Jo Changik
Department of Economics, Hallym University College of Business, Chuncheon, Korea.
Clin Mol Hepatol. 2014 Dec;20(4):327-37. doi: 10.3350/cmh.2014.20.4.327. Epub 2014 Dec 24.
Liver diseases are one of the main causes of death, and their ever-increasing prevalence is threatening to cause significant damage both to individuals and society as a whole. This damage is especially serious for the economically active population in Korea. From the societal perspective, it is therefore necessary to consider the economic impacts associated with liver diseases, and identify interventions that can reduce the burden of these diseases. The cost-of-illness study is considered to be an essential evaluation technique in health care. By measuring and comparing the economic burdens of diseases to society, such studies can help health-care decision-makers to set up and prioritize health-care policies and interventions. Using economic theories, this paper introduces various study methods that are generally applicable to most disease cases for estimating the costs of illness associated with mortality, morbidity, disability, and other disease characteristics. It also presents concepts and scopes of costs along with different cost categories from different research perspectives in cost estimations. By discussing the epidemiological and economic grounds of the cost-of-illness study, the reported results represent useful information about several evaluation techniques at an advanced level, such as cost-benefit analysis, cost-effectiveness analysis, and cost-utility analysis.
肝脏疾病是主要死因之一,其患病率不断上升,有可能对个人乃至整个社会造成重大损害。这种损害对韩国的经济活跃人口尤为严重。因此,从社会角度来看,有必要考虑与肝脏疾病相关的经济影响,并确定能够减轻这些疾病负担的干预措施。疾病成本研究被认为是医疗保健领域一项重要的评估技术。通过衡量和比较疾病给社会带来的经济负担,此类研究可帮助医疗保健决策者制定医疗保健政策和干预措施并确定其优先顺序。本文运用经济学理论,介绍了各种通常适用于大多数疾病案例的研究方法,用于估算与死亡率、发病率、残疾及其他疾病特征相关的疾病成本。同时还介绍了成本的概念和范围,以及成本估算中不同研究视角下的不同成本类别。通过探讨疾病成本研究的流行病学和经济学依据,报告结果为成本效益分析、成本效果分析和成本效用分析等高级评估技术提供了有用信息。